Advertisement
New Zealand markets open in 9 hours 43 minutes
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5958
    +0.0021 (+0.36%)
     
  • NZD/EUR

    0.5557
    +0.0011 (+0.20%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    83.13
    +0.32 (+0.39%)
     
  • GOLD

    2,341.60
    +3.20 (+0.14%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,098.17
    +57.79 (+0.72%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,992.40
    -96.30 (-0.53%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • NZD/JPY

    92.6650
    +0.5500 (+0.60%)
     

A Look at Novo Nordisk’s Financial Position

A Look at Novo Nordisk’s Financial Position

Novo Nordisk (NVO) reported revenues of 26.9 billion Danish kroner in the first quarter, compared to 28.5 billion Danish kroner in the first quarter of 2017, which reflected an ~5.0% year-over-year (or YoY) decline.